- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Short Bowel Syndrome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Short Bowel Syndrome market size is estimated to be worth US$ 457.1 million in 2021 and is forecast to a readjusted size of USD 1330.9 million by 2028 with a CAGR of 16.5% during review period. Hospitals accounting for % of the Short Bowel Syndrome global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While GLP-2 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Short Bowel Syndrome include Takeda, Merck, Emmaus Life Sciences, Nutrinia, and GlyPharma Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Short Bowel Syndrome market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
GLP-2
Growth Hormone
Glutamine
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Market segment by players, this report covers
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Short Bowel Syndrome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Short Bowel Syndrome, with revenue, gross margin and global market share of Short Bowel Syndrome from 2019 to 2022.
Chapter 3, the Short Bowel Syndrome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Short Bowel Syndrome market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Short Bowel Syndrome research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome
1.2 Classification of Short Bowel Syndrome by Type
1.2.1 Overview: Global Short Bowel Syndrome Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Short Bowel Syndrome Revenue Market Share by Type in 2021
1.2.3 GLP-2
1.2.4 Growth Hormone
1.2.5 Glutamine
1.2.6 Others
1.3 Global Short Bowel Syndrome Market by Application
1.3.1 Overview: Global Short Bowel Syndrome Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Short Bowel Syndrome Market Size & Forecast
1.5 Global Short Bowel Syndrome Market Size and Forecast by Region
1.5.1 Global Short Bowel Syndrome Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Short Bowel Syndrome Market Size by Region, (2017-2022)
1.5.3 North America Short Bowel Syndrome Market Size and Prospect (2017-2028)
1.5.4 Europe Short Bowel Syndrome Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Short Bowel Syndrome Market Size and Prospect (2017-2028)
1.5.6 South America Short Bowel Syndrome Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Short Bowel Syndrome Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Short Bowel Syndrome Market Drivers
1.6.2 Short Bowel Syndrome Market Restraints
1.6.3 Short Bowel Syndrome Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Short Bowel Syndrome Product and Solutions
2.1.4 Takeda Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Takeda Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Short Bowel Syndrome Product and Solutions
2.2.4 Merck Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 Emmaus Life Sciences
2.3.1 Emmaus Life Sciences Details
2.3.2 Emmaus Life Sciences Major Business
2.3.3 Emmaus Life Sciences Short Bowel Syndrome Product and Solutions
2.3.4 Emmaus Life Sciences Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Emmaus Life Sciences Recent Developments and Future Plans
2.4 Nutrinia
2.4.1 Nutrinia Details
2.4.2 Nutrinia Major Business
2.4.3 Nutrinia Short Bowel Syndrome Product and Solutions
2.4.4 Nutrinia Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Nutrinia Recent Developments and Future Plans
2.5 GlyPharma Therapeutics
2.5.1 GlyPharma Therapeutics Details
2.5.2 GlyPharma Therapeutics Major Business
2.5.3 GlyPharma Therapeutics Short Bowel Syndrome Product and Solutions
2.5.4 GlyPharma Therapeutics Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlyPharma Therapeutics Recent Developments and Future Plans
2.6 OxThera
2.6.1 OxThera Details
2.6.2 OxThera Major Business
2.6.3 OxThera Short Bowel Syndrome Product and Solutions
2.6.4 OxThera Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 OxThera Recent Developments and Future Plans
2.7 Ardelyx
2.7.1 Ardelyx Details
2.7.2 Ardelyx Major Business
2.7.3 Ardelyx Short Bowel Syndrome Product and Solutions
2.7.4 Ardelyx Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Ardelyx Recent Developments and Future Plans
2.8 Sancilio & Company
2.8.1 Sancilio & Company Details
2.8.2 Sancilio & Company Major Business
2.8.3 Sancilio & Company Short Bowel Syndrome Product and Solutions
2.8.4 Sancilio & Company Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Sancilio & Company Recent Developments and Future Plans
2.9 Naia Pharmaceuticals
2.9.1 Naia Pharmaceuticals Details
2.9.2 Naia Pharmaceuticals Major Business
2.9.3 Naia Pharmaceuticals Short Bowel Syndrome Product and Solutions
2.9.4 Naia Pharmaceuticals Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Naia Pharmaceuticals Recent Developments and Future Plans
2.10 Zealand Pharma
2.10.1 Zealand Pharma Details
2.10.2 Zealand Pharma Major Business
2.10.3 Zealand Pharma Short Bowel Syndrome Product and Solutions
2.10.4 Zealand Pharma Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Zealand Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Short Bowel Syndrome Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Short Bowel Syndrome Players Market Share in 2021
3.2.2 Top 10 Short Bowel Syndrome Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Short Bowel Syndrome Players Head Office, Products and Services Provided
3.4 Short Bowel Syndrome Mergers & Acquisitions
3.5 Short Bowel Syndrome New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Short Bowel Syndrome Revenue and Market Share by Type (2017-2022)
4.2 Global Short Bowel Syndrome Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Short Bowel Syndrome Revenue Market Share by Application (2017-2022)
5.2 Global Short Bowel Syndrome Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Short Bowel Syndrome Revenue by Type (2017-2028)
6.2 North America Short Bowel Syndrome Revenue by Application (2017-2028)
6.3 North America Short Bowel Syndrome Market Size by Country
6.3.1 North America Short Bowel Syndrome Revenue by Country (2017-2028)
6.3.2 United States Short Bowel Syndrome Market Size and Forecast (2017-2028)
6.3.3 Canada Short Bowel Syndrome Market Size and Forecast (2017-2028)
6.3.4 Mexico Short Bowel Syndrome Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Short Bowel Syndrome Revenue by Type (2017-2028)
7.2 Europe Short Bowel Syndrome Revenue by Application (2017-2028)
7.3 Europe Short Bowel Syndrome Market Size by Country
7.3.1 Europe Short Bowel Syndrome Revenue by Country (2017-2028)
7.3.2 Germany Short Bowel Syndrome Market Size and Forecast (2017-2028)
7.3.3 France Short Bowel Syndrome Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Short Bowel Syndrome Market Size and Forecast (2017-2028)
7.3.5 Russia Short Bowel Syndrome Market Size and Forecast (2017-2028)
7.3.6 Italy Short Bowel Syndrome Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Short Bowel Syndrome Revenue by Type (2017-2028)
8.2 Asia-Pacific Short Bowel Syndrome Revenue by Application (2017-2028)
8.3 Asia-Pacific Short Bowel Syndrome Market Size by Region
8.3.1 Asia-Pacific Short Bowel Syndrome Revenue by Region (2017-2028)
8.3.2 China Short Bowel Syndrome Market Size and Forecast (2017-2028)
8.3.3 Japan Short Bowel Syndrome Market Size and Forecast (2017-2028)
8.3.4 South Korea Short Bowel Syndrome Market Size and Forecast (2017-2028)
8.3.5 India Short Bowel Syndrome Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Short Bowel Syndrome Market Size and Forecast (2017-2028)
8.3.7 Australia Short Bowel Syndrome Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Short Bowel Syndrome Revenue by Type (2017-2028)
9.2 South America Short Bowel Syndrome Revenue by Application (2017-2028)
9.3 South America Short Bowel Syndrome Market Size by Country
9.3.1 South America Short Bowel Syndrome Revenue by Country (2017-2028)
9.3.2 Brazil Short Bowel Syndrome Market Size and Forecast (2017-2028)
9.3.3 Argentina Short Bowel Syndrome Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Short Bowel Syndrome Revenue by Type (2017-2028)
10.2 Middle East & Africa Short Bowel Syndrome Revenue by Application (2017-2028)
10.3 Middle East & Africa Short Bowel Syndrome Market Size by Country
10.3.1 Middle East & Africa Short Bowel Syndrome Revenue by Country (2017-2028)
10.3.2 Turkey Short Bowel Syndrome Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Short Bowel Syndrome Market Size and Forecast (2017-2028)
10.3.4 UAE Short Bowel Syndrome Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Short Bowel Syndrome Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Short Bowel Syndrome Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Short Bowel Syndrome Revenue (USD Million) by Region (2017-2022)
Table 5. Global Short Bowel Syndrome Revenue Market Share by Region (2023-2028)
Table 6. Takeda Corporate Information, Head Office, and Major Competitors
Table 7. Takeda Major Business
Table 8. Takeda Short Bowel Syndrome Product and Solutions
Table 9. Takeda Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Short Bowel Syndrome Product and Solutions
Table 13. Merck Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Emmaus Life Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Emmaus Life Sciences Major Business
Table 16. Emmaus Life Sciences Short Bowel Syndrome Product and Solutions
Table 17. Emmaus Life Sciences Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Nutrinia Corporate Information, Head Office, and Major Competitors
Table 19. Nutrinia Major Business
Table 20. Nutrinia Short Bowel Syndrome Product and Solutions
Table 21. Nutrinia Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlyPharma Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. GlyPharma Therapeutics Major Business
Table 24. GlyPharma Therapeutics Short Bowel Syndrome Product and Solutions
Table 25. GlyPharma Therapeutics Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. OxThera Corporate Information, Head Office, and Major Competitors
Table 27. OxThera Major Business
Table 28. OxThera Short Bowel Syndrome Product and Solutions
Table 29. OxThera Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Ardelyx Corporate Information, Head Office, and Major Competitors
Table 31. Ardelyx Major Business
Table 32. Ardelyx Short Bowel Syndrome Product and Solutions
Table 33. Ardelyx Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Sancilio & Company Corporate Information, Head Office, and Major Competitors
Table 35. Sancilio & Company Major Business
Table 36. Sancilio & Company Short Bowel Syndrome Product and Solutions
Table 37. Sancilio & Company Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Naia Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Naia Pharmaceuticals Major Business
Table 40. Naia Pharmaceuticals Short Bowel Syndrome Product and Solutions
Table 41. Naia Pharmaceuticals Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Zealand Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Zealand Pharma Major Business
Table 44. Zealand Pharma Short Bowel Syndrome Product and Solutions
Table 45. Zealand Pharma Short Bowel Syndrome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Short Bowel Syndrome Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Short Bowel Syndrome Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Short Bowel Syndrome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Short Bowel Syndrome Players Head Office, Products and Services Provided
Table 50. Short Bowel Syndrome Mergers & Acquisitions in the Past Five Years
Table 51. Short Bowel Syndrome New Entrants and Expansion Plans
Table 52. Global Short Bowel Syndrome Revenue (USD Million) by Type (2017-2022)
Table 53. Global Short Bowel Syndrome Revenue Share by Type (2017-2022)
Table 54. Global Short Bowel Syndrome Revenue Forecast by Type (2023-2028)
Table 55. Global Short Bowel Syndrome Revenue by Application (2017-2022)
Table 56. Global Short Bowel Syndrome Revenue Forecast by Application (2023-2028)
Table 57. North America Short Bowel Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Short Bowel Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Short Bowel Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Short Bowel Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Short Bowel Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Short Bowel Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Short Bowel Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Short Bowel Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Short Bowel Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Short Bowel Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Short Bowel Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Short Bowel Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Short Bowel Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Short Bowel Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Short Bowel Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Short Bowel Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Short Bowel Syndrome Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Short Bowel Syndrome Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Short Bowel Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Short Bowel Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Short Bowel Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Short Bowel Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Short Bowel Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Short Bowel Syndrome Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Short Bowel Syndrome Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Short Bowel Syndrome Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Short Bowel Syndrome Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Short Bowel Syndrome Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Short Bowel Syndrome Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Short Bowel Syndrome Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Short Bowel Syndrome Picture
Figure 2. Global Short Bowel Syndrome Revenue Market Share by Type in 2021
Figure 3. GLP-2
Figure 4. Growth Hormone
Figure 5. Glutamine
Figure 6. Others
Figure 7. Short Bowel Syndrome Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Global Short Bowel Syndrome Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Short Bowel Syndrome Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Short Bowel Syndrome Revenue Market Share by Region (2017-2028)
Figure 13. Global Short Bowel Syndrome Revenue Market Share by Region in 2021
Figure 14. North America Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Short Bowel Syndrome Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Short Bowel Syndrome Market Drivers
Figure 20. Short Bowel Syndrome Market Restraints
Figure 21. Short Bowel Syndrome Market Trends
Figure 22. Takeda Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Emmaus Life Sciences Recent Developments and Future Plans
Figure 25. Nutrinia Recent Developments and Future Plans
Figure 26. GlyPharma Therapeutics Recent Developments and Future Plans
Figure 27. OxThera Recent Developments and Future Plans
Figure 28. Ardelyx Recent Developments and Future Plans
Figure 29. Sancilio & Company Recent Developments and Future Plans
Figure 30. Naia Pharmaceuticals Recent Developments and Future Plans
Figure 31. Zealand Pharma Recent Developments and Future Plans
Figure 32. Global Short Bowel Syndrome Revenue Share by Players in 2021
Figure 33. Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Short Bowel Syndrome Revenue Market Share in 2021
Figure 35. Global Top 10 Players Short Bowel Syndrome Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Short Bowel Syndrome Revenue Share by Type in 2021
Figure 38. Global Short Bowel Syndrome Market Share Forecast by Type (2023-2028)
Figure 39. Global Short Bowel Syndrome Revenue Share by Application in 2021
Figure 40. Global Short Bowel Syndrome Market Share Forecast by Application (2023-2028)
Figure 41. North America Short Bowel Syndrome Sales Market Share by Type (2017-2028)
Figure 42. North America Short Bowel Syndrome Sales Market Share by Application (2017-2028)
Figure 43. North America Short Bowel Syndrome Revenue Market Share by Country (2017-2028)
Figure 44. United States Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Short Bowel Syndrome Sales Market Share by Type (2017-2028)
Figure 48. Europe Short Bowel Syndrome Sales Market Share by Application (2017-2028)
Figure 49. Europe Short Bowel Syndrome Revenue Market Share by Country (2017-2028)
Figure 50. Germany Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Short Bowel Syndrome Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Short Bowel Syndrome Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Short Bowel Syndrome Revenue Market Share by Region (2017-2028)
Figure 58. China Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Short Bowel Syndrome Sales Market Share by Type (2017-2028)
Figure 65. South America Short Bowel Syndrome Sales Market Share by Application (2017-2028)
Figure 66. South America Short Bowel Syndrome Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Short Bowel Syndrome Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Short Bowel Syndrome Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Short Bowel Syndrome Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Short Bowel Syndrome Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
